Omnicell Inc reports results for the quarter ended in March - Earnings Summary

Omnicell

03/05/2024 20:16

* Omnicell Inc  OMCL.OQ  reported quarterly adjusted
earnings of 3
cents​​ per share for the quarter ended in March, lower than the
same quarter last year, when the company reported EPS of 39
cents.  The mean expectation of nine analysts for the quarter
was for a loss of 9 cents per share. Wall Street expected
results to range from -21 cents to -4 cents per share.
    * Revenue fell 15.3% to $246.15 million from a year ago;
analysts
expected $236.75 million. 
    * Omnicell Inc's reported EPS for the quarter was a loss
of 34
cents​.
    * The company reported a quarterly loss of $15.68 million.
    * Omnicell Inc shares had risen by 0.2% this quarter and
lost 22.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 130.6% in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 4
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "hold"

Wall Street's median 12-month price target for Omnicell Inc is
$37.00 
This summary was machine generated from LSEG data May 3 at 07:16
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.09          0.03           Beat
 Dec. 31 2023      0.15           0.33           Beat
 Sep. 30 2023      0.47           0.62           Beat
 Jun. 30 2023      0.28           0.57           Beat